• 1
    Potosky AL, Legler J, Albertsen PC, et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2000; 92: 1582-1592.
  • 2
    Madalinska JB, Essink-Bot ML, de Koning HJ, Kirkels WJ, van der Maas PJ, Schroder FH. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol. 2001; 19: 1619-1628.
  • 3
    Wei JT, Dunn RL, Sandler HM, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol. 2002; 20: 557-566.
  • 4
    Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004: 1-19.
  • 5
    Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Health Stat Report. 2009: 1-14.
  • 6
    White JD. Complementary and alternative medicine research: a National Cancer Institute perspective. Semin Oncol. 2002; 29: 546-551.
  • 7
    DiGianni LM, Garber JE, Winer EP. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol. 2002; 20: 34S-38S.
  • 8
    Boon H, Westlake K, Stewart M, et al. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology. 2003; 62: 849-853.
  • 9
    Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology. 2005; 66: 1223-1228.
  • 10
    Eng J, Ramsum D, Verhoef M, Guns E, Davison J, Gallagher R. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther. 2003; 2: 212-216.
  • 11
    Hall JD, Bissonette EA, Boyd JC, Theodorescu D. Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: results of a pilot study. BJU Int. 2003; 91: 603-607.
  • 12
    Nam RK, Fleshner N, Rakovitch E, et al. Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis. J Urol. 1999; 161: 1521-1524.
  • 13
    Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P. A prospective study of the use of alternative therapies by men with localized prostate cancer. Patient Educ Couns. 2004; 55: 70-77.
  • 14
    Wilkinson S, Gomella LG, Smith JA, et al. Attitudes and use of complementary medicine in men with prostate cancer. J Urol. 2002; 168: 2505-2509.
  • 15
    Gallob R. Reiki: a supportive therapy in nursing practice and self-care for nurses. J N Y State Nurses Assoc. 2003; 34: 9-13.
  • 16
    Kovalik D. Reiki as an alternative healing method. Common Factor. 1995(no 10): 9.
  • 17
    Miles P, True G. Reiki-review of a biofield therapy history, theory, practice, and research. Altern Ther Health Med. 2003; 9: 62-72.
  • 18
    Engebretson J, Wardell DW. Energy-based modalities. Nurs Clin North Am. 2007; 42: 243-259, vi.
  • 19
    Pierce B. The use of biofield therapies in cancer care. Clin J Oncol Nurs. 2007; 11: 253-258.
  • 20
    Tsang KL, Carlson LE, Olson K. Pilot crossover trial of Reiki versus rest for treating cancer-related fatigue. Integr Cancer Ther. 2007; 6: 25-35.
  • 21
    Beary JF, Benson H. A simple psychophysiologic technique which elicits the hypometabolic changes of the relaxation response. Psychosom Med. 1974; 36: 115-120.
  • 22
    Benson H, Greenwood MM, Klemchuk H. The relaxation response: psychophysiologic aspects and clinical applications. Int J Psychiatry Med. 1975; 6: 87-98.
  • 23
    Rapp MS, Thomas MR, Leith MG. Muscle relaxation techniques: a therapeutic tool for family physicians. Can Med Assoc J. 1984; 130: 691-694.
  • 24
    Stetter F, Kupper S. Autogenic training: a meta-analysis of clinical outcome studies. Appl Psychophysiol Biofeedback. 2002; 27: 45-98.
  • 25
    Dusek JA, Otu HH, Wohlhueter AL, et al. Genomic counter-stress changes induced by the relaxation response. PLoS One. 2008; 3: e2576.
  • 26
    Spielberger C, Gorsuch R, Lushene R. STAI Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.
  • 27
    Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement. 1977; 1: 385-401.
  • 28
    Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993; 11: 570-579.
  • 29
    Bonferroni CE. Teoria statistica delle classi e calcolo delle probabilita. Pubblicazioni del R Istituto Superiore di Scienze Economiche e Commerciali di Firenze. 1936; 8: 3-62.
  • 30
    Wilcoxon F. Individual comparisons by ranking methods. Biometrics. 1945; 1: 80-83.
  • 31
    Rehse B, Pukrop R. Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies. Patient Educ Couns. 2003; 50: 179-186.
  • 32
    Johnstone PA, Bloom TL, Niemtzow RC, Crain D, Riffenburgh RH, Amling CL. A prospective, randomized pilot trial of acupuncture of the kidney-bladder distinct meridian for lower urinary tract symptoms. J Urol. 2003; 169: 1037-1039.
  • 33
    Penedo FJ, Molton I, Dahn JR, et al. A randomized clinical trial of group-based cognitive-behavioral stress management in localized prostate cancer: development of stress management skills improves quality of life and benefit finding. Ann Behav Med. 2006; 31: 261-270.